Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 1/20 | 0.37 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.35 |
| ▸ | ALPI | P09923 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | XIAP | P98170 | 1/20 | 0.34 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.34 |
| ▸ | ANPEP | P15144 | 1/20 | 0.34 |
| ▸ | LAP3 | P28838 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LTA4H | P09960 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.33 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7782151 | 1.00 | SLC1A3 (0.37) | SLC1A3SCN9AATML3MBTL1CYP1A2 | |
| SCHEMBL1171906 | 0.86 | ITGB3 (0.46) | CYP1A2ALPIPKMPTGS1XIAP | |
| Histidine SCHEMBL8315963 | 0.86 | ITGB3 (0.46) | CYP1A2ALPIPKMPTGS1XIAP | |
| Histidine SCHEMBL8316688 | 0.86 | ITGB3 (0.46) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL2678594 | 0.84 | MAOB (0.39) | SCN9AATMALDH1A1LTA4HMEN1 | |
| SCHEMBL8015382 | 0.83 | ALDH1A1 (0.42) | SCN9APKMALDH1A1MEN1KMT2A | |
| SCHEMBL28129418 | 0.83 | BCL9 (0.40) | L3MBTL1PKMALDH1A1KMT2AMAPT | |
| SCHEMBL19063571 | 0.83 | ANPEP (0.40) | SCN9AANPEPLAP3 | |
| SCHEMBL729057 | 0.83 | LTA4H (0.44) | SLC1A3ALPIPKMPTGS1XIAP | |
| SCHEMBL3155213 | 0.83 | ALPI (0.46) | SLC1A3ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11045523-B2 | Formulation of growth hormone albumin-binder conjugate | NOVO NORDISK HEALTHCARE AG (CH) | 2021-06-29 | — | — | US | disclosed |
| EP-2981282-B1 | GROWTH HORMONE COMPOUND FORMULATION | NOVO NORDISK HEALTHCARE AG (CH) | 2020-11-04 | — | — | EP | disclosed |
| US-20160058879-A1 | Growth Hormone Compound Formulation | NOVO NORDISK HEALTHCARE AG (CH) | 2016-03-03 | — | — | US | disclosed |
| EP-2981282-A1 | GROWTH HORMONE COMPOUND FORMULATION | Novo Nordisk Health Care AG (CH) | 2016-02-10 | — | — | EP | disclosed |
| CN-105120887-A | Growth hormone compound formulation | NOVO NORDISK HEALTHCARE AG | 2015-12-02 | — | — | CN | disclosed |
| WO-2014166836-A1 | GROWTH HORMONE COMPOUND FORMULATION | NOVO NORDISK A/S (DK) | 2014-10-16 | — | — | WO | disclosed |
| EP-1135398-A1 | CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION | Monsanto Technology LLC (US) | 2001-09-26 | — | — | EP | disclosed |
| US-6218563-B1 | Cyanophosphonamides and method for preparation | MONSANTO COMPANY | 2001-04-17 | — | — | US | disclosed |
| WO-2000032611-A1 | CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION | MONSANTO TECHNOLOGY LLC (US) | 2000-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11045523-B2 | Formulation of growth hormone albumin-binder conjugate | ALB, SHBG, SERPINA6 | SLC1A3 2356/4885SCN9A 4512/4885ATM 3702/4885 |
| US-20160058879-A1 | Growth Hormone Compound Formulation | GHRHR, GHSR, GHITM | SLC1A3 3131/4885SCN9A 4451/4885ATM 3817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.